NHS NEL
Demonstration Formulary
Demonstration Formulary
5 Infections
This formulary indicates prescribing status only, for guidance on managing infections please refer to your local antibiotic guidelines
Summary of antimicrobial prescribing guidance - managing common infections
05-03-03-02 Chronic hepatitis C
| Glecaprevir-pibrentasvir Maviret® |
|
Formulary
|
In line with NICE |
 NICE TA499: Glecaprevir–pibrentasvir for treating chronic hepatitis C |
|
| Ledipasvir/sofosbuvir Harvoni® |
|
Formulary
|
In line with NICE |
|
NICE TA363: Ledipasvir–sofosbuvir for treating chronic hepatitis C |
|
|
| Sofosbuvir/Velpatasvir/Voxilaprevir Vosevi® |
|
Formulary
|
In line with NICE |
|
NICE TA507: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C |
|
|
| Sofosbuvir/velpatasvir Epclusa® |
|
Formulary
|
In line with NICE |
|
NICE TA430: Sofosbuvir–velpatasvir for treating chronic hepatitis C |
|
|
Links
- NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use
- NICE NG199: Clostridioides difficile infection: antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing (visual summary)
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA252: Telaprevir for the treatment of genotype 1 chronic hepatitis C
- NICE TA253: Boceprevir for the treatment of genotype 1 chronic hepatitis C
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA363: Ledipasvir–sofosbuvir for treating chronic hepatitis C
- NICE TA364: Daclatasvir for treating chronic hepatitis C
- NICE TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
- NICE TA430: Sofosbuvir–velpatasvir for treating chronic hepatitis C
- NICE TA499: Glecaprevir–pibrentasvir for treating chronic hepatitis C
- NICE TA507: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
Summary of antimicrobial prescribing guidance - managing common infections